# Aptivus

NDC: 0597-0003
Generic name: tipranavir
Labeler / Manufacturer: Boehringer Ingelheim Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CAPSULE, LIQUID FILLED
Routes: ORAL
Marketing started: 20050701

FDA application: NDA021814

## Active ingredients

- TIPRANAVIR: 250 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0597-0003"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0597-0003
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=08982e49-d2eb-4b25-b01a-1be52fd669ef